The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Phenotypic screens as a renewed approach for drug discovery
Open accessAbstract
The significant reduction in the number of newly approved drugs in past decade has been partially attributed to failures in discovery and validation of new targets. Evaluation of recently approved new drugs has revealed that the number of approved drugs discovered through phenotypic screens, an original drug screening paradigm, has exceeded those discovered through the molecular target-based approach. Phenotypic screening is thus gaining new momentum in drug discovery with the hope that this approach may revitalize drug discovery and improve the success rate of drug approval through the discovery of viable lead compounds and identification of novel drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Analysis of apoptosis by propidium iodide staining and flow cytometry
Riccardi, C., & Nicoletti, I. (2006) · Nature Protocols · doi:10.1038/nprot.2006.238 · Cited by 1,685
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Primary structure of the receptor for calcium channel blockers from skeletal muscle
Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., & Numa, S. (1987) · Nature · doi:10.1038/328313a0 · Cited by 1,371
The mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,136
Rampersad, S. N. (2012) · Sensors · doi:10.3390/s120912347 · Cited by 1,068
Trends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439 · Cited by 622
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Self-citationSystems biology in drug discovery
Butcher, E. C., Berg, E. L., & Kunkel, E. J. (2004) · Nature Biotechnology · doi:10.1038/nbt1017 · Cited by 605
A functionally characterized test set of human induced pluripotent stem cells
Boulting, G. L., Kiskinis, E., Croft, G. F., Amoroso, M. W., Oakley, D. H., Wainger, B. J., Williams, D. J., Kahler, D. J., Yamaki, M., Davidow, L., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1783 · Cited by 489
Phase III and submission failures: 2007–2010
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3375 · Cited by 480
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
High content screening: seeing is believing
Zanella, F., Lorens, J. B., & Link, W. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.02.005 · Cited by 391
Elliott, W. J., & Ram, C. V. S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00513.x · Cited by 368
Origin and evolution of high throughput screening
Pereira, D. A., & Williams, J. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707373 · Cited by 364
Rosenblum, S. B., Huynh, T., Afonso, A., Davis, H. R., Yumibe, N., Clader, J. W., & Burnett, D. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970701f · Cited by 361
History of calcium antagonists.
Fleckenstein, A. (1983) · PubMed · Cited by 315
Van Heek, M., France, C. F., Compton, D. S., Mcleod, R. L., Yumibe, N. P., Alton, K. B., Sybertz, E. J., & Davis, H. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36992-7 · Cited by 305
High‐throughput screening and small animal models, where are we?
Giacomotto, J., & Ségalat, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00725.x · Cited by 293
A safe lithium mimetic for bipolar disorder
Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O. V., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I., Sharp, T., Vasudevan, S. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms2320 · Cited by 258
Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening
Xia, M., Huang, R., Witt, K. L., Southall, N., Fostel, J., Cho, M.-H., Jadhav, A., Smith, C. S., Inglese, J., Portier, C. J., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10727 · Cited by 255
Miller, S. C., Huang, R., Sakamuru, S., Shukla, S. J., Attene-Ramos, M. S., Shinn, P., Van Leer, D., Leister, W., Austin, C. P., & Xia, M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.021 · Cited by 250
Calcium channel antagonists: Clinical uses—Past, present and future
Triggle, D. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.016 · Cited by 248
Genomic sciences and the medicine of tomorrow
Drews, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1516 · Cited by 246
Lee, G., Ramirez, C. N., Kim, H., Zeltner, N., Liu, B., Radu, C., Bhinder, B., Kim, Y. J., Choi, I. Y., Mukherjee-Clavin, B., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2435 · Cited by 225
Cell-Based Assays for High-Throughput Screening
An, W. F., & Tolliday, N. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9251-z · Cited by 220
Cell-based assays: fuelling drug discovery
Michelini, E., Cevenini, L., Mezzanotte, L., Coppa, A., & Roda, A. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3933-z · Cited by 197
Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings
Braungart, E., Gerlach, M., Riederer, P., Baumeister, R., & Hoener, M. C. (2004) · Neurodegenerative Diseases · doi:10.1159/000080983 · Cited by 186
Identifying mechanism-of-action targets for drugs and probes
Gregori-Puigjané, E., Setola, V., Hert, J., Crews, B. A., Irwin, J. J., Lounkine, E., Marnett, L., Roth, B. L., & Shoichet, B. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204524109 · Cited by 182
The BRET technology and its application to screening assays
Bacart, J., Corbel, C., Jockers, R., Bach, S., & Couturier, C. (2008) · Biotechnology Journal · doi:10.1002/biot.200700222 · Cited by 178
Human stem cells and drug screening: opportunities and challenges
Ebert, A. D., & Svendsen, C. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3000 · Cited by 172
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Scott, C. W., Peters, M. F., & Dragan, Y. P. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.020 · Cited by 171
Kang, S., Cooper, G., Dunne, S. F., Dusel, B., Luan, C.-H., Surmeier, D. J., & Silverman, R. B. (2012) · Nature Communications · doi:10.1038/ncomms2149 · Cited by 169
Use of Reprogrammed Cells to Identify Therapy for Respiratory Papillomatosis
Yuan, H., Myers, S., Wang, J., Zhou, D., Woo, J. A., Kallakury, B., Ju, A., Bazylewicz, M., Carter, Y. M., Albanese, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203055 · Cited by 169
Zebrafish screen identifies novel compound with selective toxicity against leukemia
Ridges, S., Heaton, W. L., Joshi, D., Choi, H., Eiring, A. M., Batchelor, L. A., Choudhry, P., Manos, E. J., Sofla, H., Sanati, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398818 · Cited by 156
Targeting cell signaling pathways for drug discovery: An old lock needs a new key
Aggarwal, B. B., Sethi, G., Baladandayuthapani, V., Krishnan, S., & Shishodia, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21500 · Cited by 155
A cell-based screen for drugs to treat Huntington's disease
Aiken, C. T., Tobin, A. J., & Schweitzer, E. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.001 · Cited by 139
Neuberger, T. J., Burton, B., Clark, H., & Goor, F. V. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-117-8_4 · Cited by 137
Textbook of Receptor Pharmacology
Foreman, J. C., Johansen, T., & Gibb, A. J. (2010) · CRC Press eBooks · doi:10.1201/9781420052558 · Cited by 127
Xu, M., Liu, K., Swaroop, M., Porter, F. D., Sidhu, R., Finkes, S., Ory, D. S., Marugán, J., Xiao, J., Southall, N. T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357707 · Cited by 125
Self-citationCurrent status of drug screening and disease modelling in human pluripotent stem cells
Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A. K., George, V. T., & Denning, C. N. (2012) · BioEssays · doi:10.1002/bies.201200053 · Cited by 119
Ramaekers, F., & Bosman, F. (2004) · Journal of Pathology · doi:10.1002/path.1665 · Cited by 116
Neumann, S., Huang, W., Titus, S., Krause, G., Kleinau, G., Alberobello, A. T., Zheng, W., Southall, N. T., Inglese, J., Austin, C. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904506106 · Cited by 114
Self-citationEzetimibe: A Selective Cholesterol Absorption Inhibitor
Nutescu, E. A., & Shapiro, N. L. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.14.1463.31942 · Cited by 111
Novel human bronchial epithelial cell lines for cystic fibrosis research
Fulcher, M. L., Gabriel, S. E., Olsen, J. C., Tatreau, J. R., Gentzsch, M., Livanos, E., Saavedra, M. T., Salmon, P., & Randell, S. H. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90314.2008 · Cited by 105
Applications of High Content Screening in Life Science Research
Zock, J. M. (2009) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620709789383277 · Cited by 102
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening
Eglen, R., & Reisine, T. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0305 · Cited by 100
Cho, M.-H., Niles, A. L., Huang, R., Inglese, J., Austin, C. P., Riss, T., & Xia, M. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.02.013 · Cited by 97
An Historical Overview of Drug Discovery
Pina, A. S., Hussain, A., & Roque, A. C. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-244-5_1 · Cited by 91
Classical vs reverse pharmacology in drug discovery
Takenaka, T. (2001) · British Journal of Urology · doi:10.1111/j.1464-410x.2001.00112.x · Cited by 78
Zhao, W., Cheng, C., Theriault, K. M., Sheridan, S. D., Tsai, L., & Haggarty, S. J. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112456876 · Cited by 76
Mcneish, J., Roach, M. L., Hambor, J., Mather, R., Weibley, L., Lazzaro, J., Gazard, J., Schwarz, J. A., Volkmann, R., Machacek, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098814 · Cited by 74
Rosenbaum, A. I., Rujoi, M., Huang, A. Y., Du, H., Grabowski, G. A., & Maxfield, F. R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.005 · Cited by 64
Drug repurposing through nonhypothesis driven phenotypic screening
Reaume, A. G. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.09.007 · Cited by 61
McLaren, D., Gorba, T., de Rotrou, A. M., Pillai, G. R., Chappell, C., Stacey, A., Lingard, S., Falk, A., Smith, A. G., Koch, P., et al. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112461446 · Cited by 51
Camus, S., Quevedo, C., Ménendez, S., Paramonov, I., Stouten, P. F. W., Janssen, R. A. J., Rueb, S., He, S., Snaar-Jagalska, E. B., Laricchia‐Robbio, L., et al. (2011) · Oncogene · doi:10.1038/onc.2011.594 · Cited by 50
Zhang, L., He, M., Zhang, Y., Nilubol, N., Shen, M., & Kebebew, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2671 · Cited by 46
Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators
Xiao, J., Marugán, J., Zheng, W., Titus, S., Southall, N. T., Cherry, J. J., Evans, M., Androphy, E. J., & Austin, C. P. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200497t · Cited by 45
Self-citationNilubol, N., Zhang, L., Shen, M., Zhang, Y., He, M., Austin, C. P., & Kebebew, E. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-198 · Cited by 40
Identification of repurposed small molecule drugs for chordoma therapy
Xia, M., Huang, R., Sakamuru, S., Alcorta, D. A., Cho, M.-H., Lee, D., Park, D. M., Kelley, M. J., Sommer, J., & Austin, C. P. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24596 · Cited by 39
Patient-derived stem cells: pathways to drug discovery for brain diseases
Mackay‐Sim, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00029 · Cited by 30
The synergy between combinatorial chemistry and high-throughput screening.
Diller, D. J. (2008) · PubMed · Cited by 29
Titus, S. A., Southall, N. T., Marugán, J., Austin, C. P., & Zheng, W. (2012) · Current Chemical Genomics · doi:10.2174/1875397301206010079 · Cited by 29
Self-citationG-protein-coupled receptors in drug discovery
Saunders, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.001 · Cited by 27
Barabasz, A. F., Foley, B. E., Otto, J. C., Scott, A., & Rice, J. W. (2006) · Assay and Drug Development Technologies · doi:10.1089/adt.2006.4.153 · Cited by 26
Cell-Cycle Inhibitor Profiling by High-Content Analysis
Gasparri, F., Ciavolella, A., & Galvani, A. P. (2007) · Springer eBooks · doi:10.1007/978-0-387-69116-9_13 · Cited by 22
G Protein-Coupled Receptors in Drug Discovery
(2009) · Methods in molecular biology · doi:10.1007/978-1-60327-317-6 · Cited by 20
Vogt, A., & Lazo, J. S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.002 · Cited by 17
Molecular Sensors for Transcriptional and Post-Transcriptional Assays
Auld, D. S., & Thorne, N. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139021500.018 · Cited by 2
Self-citation
Cited by
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Drug repurposing: a promising tool to accelerate the drug discovery process
Parvathaneni, V., Kulkarni, N. S., Muth, A., & Gupta, V. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.014 · Cited by 597
The discovery of first-in-class drugs: origins and evolution
Eder, J., Sedrani, R., & Wiesmann, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4336 · Cited by 514
“12% (9) 3% (2) 1% (1) 22% (17) 10% (8) 5% (4) 21% (16) 6% (2)”
Drug combination therapy increases successful drug repositioning
Sun, W., Sanderson, P. E., & Zheng, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.015 · Cited by 436
Self-citation
Metadata
- Authors
- Zheng, W., Thorne, N., & McKew, J. C.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 18
- Issue
- 21-22
- Pages
- 1067-1073
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1981066521
- Cited by
- 423
- References
- 78
- FWCI
- 32.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.